International clinician perspectives on pandemic-associated stress in supporting people with intellectual and developmental disabilities

Joshua Howkins, Angela Hassiotis, Elspeth Bradley, Andrew Levitas, Tanja Sappok, Amanda Sinai, Anupam Thakur, Rohit Shankar, Joshua Howkins, Angela Hassiotis, Elspeth Bradley, Andrew Levitas, Tanja Sappok, Amanda Sinai, Anupam Thakur, Rohit Shankar

Abstract

Background: People living with intellectual and developmental disabilities (IDD) have suffered disproportionately in health outcomes and general well-being during the COVID-19 pandemic. There is emerging evidence of increased psychological distress. Increased strain has also fallen on clinicians managing the psychological needs of people with IDD, in the context of learning new technologies, staff shortages, reduced services and paused training opportunities.

Aims: To examine clinicians' experiences of patient care, clinical management and the impact of care delivery.

Method: A mixed fixed-response and free-text survey comprising 28 questions covering four areas (responder demographics, clinical practice, changes to local services and clinician experiences) was developed, using the STROBE guidance. It was disseminated through an exponential snowballing technique to clinicians in seven high-income countries. Quantitative data were analysed and presented with Microsoft Excel. Qualitative data were coded and thematically analysed, and presented with in-text quotations.

Results: There were 139 respondents, mostly senior physicians (71%). Two-thirds reported over 10 years working in the field. Quantitative findings include increased clinician stress (77%), referrals (53%), patient distress presentations (>70%), patient isolation (73%) and carer burden (89%), and reduced patient participation in daily activities (86%). A third reported increased psychotropic prescribing. Qualitative analysis outlined changes to clinical practice, particularly the emergence and impact of telehealth.

Conclusions: In the countries surveyed, the pandemic has not only had a significant impact on people with IDD, but also their carers and clinicians. A proactive, holistic international response is needed in preparedness for future public health emergencies.

Keywords: Intellectual disability; developmental disorders; patients; psychosocial interventions; transcultural psychiatry.

Conflict of interest statement

T.S. receives royalties from different publishers, including Hogrefe and Kohlhammer. R.S. has received institutional and research support from LivaNova, GW Pharma, Union Chimique Belge, Eisai, Veriton Pharma, Averelle and Destin, outside the submitted work. No other author has declared any conflict of interest related to this work.

References

    1. NHS England, NHS Improvement. COVID-19 Deaths of Patients with a Learning Disability Notified to LeDeR. NHS England, 2020 ().
    1. Public Health England. Deaths of People Identified as Having Learning Disabilities with COVID-19 in England in the Spring of 2020. Public Health England, 2020 ().
    1. Sheehan R, Dalton-Locke C, Ali A, Vera San Juan N, Totsika V, Hassiotis A. Effects of the COVID-19 pandemic on mental healthcare and services: results of a UK survey of front-line staff working with people with intellectual disability and/or autism. BJPsych Bull [Epub ahead of print] 12 May 2021. Available from: 10.1192/bjb.2021.52.
    1. Perera B, Laugharne R, Henley W, Zabel A, Lamb K, Branford D, et al. COVID-19 deaths in people with intellectual disability in the UK and Ireland: descriptive study. BJPsych Open 2020; 6(6): E123.
    1. Embregts PJCM, van den Bogaard KJHM, Frielink N, Voermans MAC, Thalen M, Jahoda A. A thematic analysis into the experiences of people with a mild intellectual disability during the COVID-19 lockdown period. Int J Dev Disabil [Epub ahead of print] 5 Oct 2020. Available from: 10.1080/20473869.2020.1827214.
    1. Hughes N, Anderson G. The experience of the COVID-19 pandemic in a UK learning disability service: lost in a sea of ever changing variables – a perspective. Int J Dev Disabil [Epub ahead of print] 1 Jun 2020. Available from: 10.1080/20473869.2020.1773711.
    1. Courtenay K, Perera B. COVID-19 and people with intellectual disability: impacts of a pandemic. Ir J Psychol Med 2020; 37(3): 231–6.
    1. Willner P, Rose J, Stenfert Kroese B, Murphy GH, Langdon PE, Clifford C, et al. Effect of the COVID-19 pandemic on the mental health of carers of people with intellectual disabilities. J Appl Res Intellect Disabil 2020; 33: 1523–33.
    1. Rose J, Willner P, Cooper V, Langdon PE, Murphy GH, Kroese BS. The effect on and experience of families with a member who has intellectual and developmental disabilities of the COVID-19 pandemic in the UK: developing an investigation. Int J Dev Disabil [Epub ahead of print] 15 May 2020. Available from: 10.1080/20473869.2020.1764257.
    1. Paulauskaite L, Farris O, Spencer HM, group EPICC-ID, Hassiotis A. My son can't socially distance or wear a mask: how families of preschool children with severe developmental delays and challenging behavior experienced the COVID-19 pandemic. J Ment Health Res Intellect Disabil 2021; 14(2): 225–36.
    1. Courtenay K, Perera B. COVID-19 and people with intellectual disability: impacts of a pandemic. Ir J Psychol Med 2020; 37(3): 231–6.
    1. Branford D, Gerrard D, Saleem N, Shaw C, Webster A. Stopping Over-medication of People with Intellectual Disability, Autism or Both (STOMP) in England Part 1–history and background of STOMP. Adv Ment Health Intell Disabil 2019; 13: 31–40.
    1. Rauf B, Sheikh H, Majid H, Roy A, Pathania R. COVID-19-related prescribing challenge in intellectual disability. BJPsych Open 2021; 7(2): E66.
    1. Naqvi D, Perera B, Mitchell S, Rory Sheehan R, Shankar R. COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services. BJPsych Open 2022; 8(1): E7.
    1. Tromans S, Kinney M, Chester V, Alexander R, Roy A, Sander J, et al. Priority concerns for people with intellectual and developmental disabilities during the COVID-19 pandemic. BJPsych Open 2020; 6(6): E128.
    1. Johnson S, Dalton-Locke C, Vera San Juan N, Foye U, Oram S, Papamichail A, et al. Impact on mental health care and on mental health service users of the COVID-19 pandemic: a mixed methods survey of UK mental health care staff. Soc Psychiatry Psychiatr Epidemiol 2021; 56: 25–37.
    1. Byrne A, Barber R, Lim CH. Impact of the COVID-19 pandemic – a mental health service perspective. Prog Neurol Psychiatry 2021; 25: 27–33b.
    1. Tam MT, Dosso JA, Robillard JM. The impact of a global pandemic on people living with dementia and their care partners: analysis of 417 lived experience reports. J Alzheimers Dis 2021; 80(2): 865–75.
    1. Masterson-Algar P, Allen MC, Hyde M, Keating N, Windle G. Exploring the impact of Covid-19 on the care and quality of life of people with dementia and their carers: a scoping review. Dementia 2022; 21(2): 648–76.
    1. Sparasci O, Bhui K, Biswas A, Chamberlin S, Dubicka B, Dudas R, et al. Impact of COVID-19 on mental health research: is this the breaking point? Br J Psychiatry [Epub ahead of print] 17 Feb 2022. Available from: 10.1192/bjp.2022.8.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj